Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.

Dhyani A, Tezcan N, Chou JF, Tarcan Z, Thummalapalli R, Nagib F, Fitzpatrick OM, Cowzer D, Khalil DN, Park W, Saadat LV, Soares K, Wei A, Jarnagin W, Schultz N, Erinjeri JP, Dunphy M, Solit D, Chatila W, O'Reilly EM, Abou-Alfa GK, Capanu M, Basturk O, Harding JJ

Open source

DOI: 10.1158/1078-0432.ccr-26-1720
Published: 2026 Sep 10
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-1720,
  title = {Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.},
  author = {Dhyani A and Tezcan N and Chou JF and Tarcan Z and Thummalapalli R and Nagib F and Fitzpatrick OM and Cowzer D and Khalil DN and Park W and Saadat LV and Soares K and Wei A and Jarnagin W and Schultz N and Erinjeri JP and Dunphy M and Solit D and Chatila W and O'Reilly EM and Abou-Alfa GK and Capanu M and Basturk O and Harding JJ},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-1720},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-1720}
}

RIS

TY  - JOUR
TI  - Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.
AU  - Dhyani A
AU  - Tezcan N
AU  - Chou JF
AU  - Tarcan Z
AU  - Thummalapalli R
AU  - Nagib F
AU  - Fitzpatrick OM
AU  - Cowzer D
AU  - Khalil DN
AU  - Park W
AU  - Saadat LV
AU  - Soares K
AU  - Wei A
AU  - Jarnagin W
AU  - Schultz N
AU  - Erinjeri JP
AU  - Dunphy M
AU  - Solit D
AU  - Chatila W
AU  - O'Reilly EM
AU  - Abou-Alfa GK
AU  - Capanu M
AU  - Basturk O
AU  - Harding JJ
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-26-1720
UR  - https://doi.org/10.1158/1078-0432.ccr-26-1720
ER  -

APA

A, D., N, T., JF, C., Z, T., R, T., F, N., OM, F., D, C., DN, K., W, P., LV, S., K, S., A, W., W, J., N, S., JP, E., M, D., D, S., W, C., EM, O., GK, A., M, C., O, B., & JJ, H. (2026). Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-1720

Source records

pubmed · retrieved 2026-09-26T04:55:50.367Z